411 related articles for article (PubMed ID: 33657293)
1. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
[TBL] [Abstract][Full Text] [Related]
2. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.
China L; Muirhead N; Skene SS; Shabir Z; De Maeyer RP; Maini A; Gilroy DW; O'Brien AJ
BMJ Open; 2016 Jan; 6(1):e010132. PubMed ID: 26810999
[TBL] [Abstract][Full Text] [Related]
3. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial.
China L; Skene SS; Bennett K; Shabir Z; Hamilton R; Bevan S; Chandler T; Maini AA; Becares N; Gilroy D; Forrest EH; O'Brien A
BMJ Open; 2018 Oct; 8(10):e023754. PubMed ID: 30344180
[TBL] [Abstract][Full Text] [Related]
4. Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; O'Brien A
Am J Gastroenterol; 2021 Nov; 116(11):2292-2295. PubMed ID: 34520431
[TBL] [Abstract][Full Text] [Related]
5. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; Piano S; Elia C; Prestianni L; Cappa FM; Cesarini L; Simone L; Pasquale C; Cavallin M; Andrealli A; Fidone F; Ruggeri M; Roncadori A; Baldassarre M; Tufoni M; Zaccherini G; Bernardi M;
Lancet; 2018 Jun; 391(10138):2417-2429. PubMed ID: 29861076
[TBL] [Abstract][Full Text] [Related]
6. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
[TBL] [Abstract][Full Text] [Related]
8. Albumin infusion in liver cirrhotic patients.
Rena NM; Wibawa ID
Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis.
Khanna D; Kar P; Sahu P
Indian J Gastroenterol; 2024 Apr; 43(2):494-504. PubMed ID: 38722510
[TBL] [Abstract][Full Text] [Related]
10. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
[TBL] [Abstract][Full Text] [Related]
11. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
[TBL] [Abstract][Full Text] [Related]
12. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
N Engl J Med; 1999 Aug; 341(6):403-9. PubMed ID: 10432325
[TBL] [Abstract][Full Text] [Related]
14. Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis.
China L; Becares N; Rhead C; Tittanegro T; Freemantle N; O'Brien A
Clin Transl Gastroenterol; 2022 May; 13(5):e00476. PubMed ID: 35333783
[TBL] [Abstract][Full Text] [Related]
15. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
16. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
Bernardi M; Caraceni P; Navickis RJ
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
[No Abstract] [Full Text] [Related]
17. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
[TBL] [Abstract][Full Text] [Related]
18. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
19. Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial.
China L; Skene SS; Shabir Z; Maini A; Sylvestre Y; Bennett K; Bevan S; O'Beirne J; Forrest E; Portal J; Ryder S; Wright G; Gilroy DW; O'Brien A
Clin Gastroenterol Hepatol; 2018 May; 16(5):748-755.e6. PubMed ID: 28911947
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]